Professional Documents
Culture Documents
04/13/09
Asthma-Pathology -3
Objectives:
At the end of the discussion the
students will be able to:
Define Bronchial Asthma
Discuss the anatomy and physiology of
the respiratory system
Discuss the pathophysiology of
bronchial asthma
State the different medical management
for bronchial asthma
04/13/09 Shashi
Asthma-Pathology -4
04/13/09 Shashi
Asthma-Pathology -5
04/13/09 Shashi
Asthma-Pathology -7
04/13/09 Shashi
Asthma-Pathology -8
Asthma:
Chronic Inflammatory disorder of
bronchi characterized by Episodic,
reversible bronchospasm resulting
from an exaggerated
bronchoconstrictor response to
various stimuli (allergy)
Affects 10% of children & 5%-7%
adults ♥
04/13/09 Shashi
Asthma-Pathology -9
Asthma Facts ?
Asthma is “all in the mind.”
You will “grow out of it.”
Asthma can be cured,
Not very serious disease and nobody dies from it.
You are likely to develop asthma if someone in
your family has it.
You can “catch” asthma from someone else who
has it.
Moving to a different location can cure asthma.
People with asthma should not exercise.
Asthma does not require medical treatment.
Medications used to treat asthma are habit-
forming.
Someone with asthma can provoke episodes
anytime.
Asthma can spread to other persons through
04/13/09 Shashi
Asthma-Pathology -10
Percent Change in Age-
Adjusted Death Rates, U.S.,
1965-1998
Proportion of 1965 Rate
3.0
Coronary Stroke Other CVD COPD All Other
2.5 Heart Causes
Disease
2.0
1.5
1.0
0.5
–59% –64% –35% +163% –7%
0
1965 - 1998 1965 - 1998 1965 - 1998 1965 - 1998 1965 - 1998
04/13/09 Shashi
Asthma-Pathology -11
Anatomy Physiology
04/13/09 Shashi
Asthma-Pathology -12
..continuation of Anatomy
The main function of the respiratory
system is to move air into the lungs so
that oxygen can enter the body and
carbon dioxide can be exhaled. During
breathing, air passes from the nose and
mouth into the pharynx and through the
larynx into the trachea. The trachea
bifurcates to carry air into each lung.
These two tubes are the main stem
bronchi; there is a single left main stem
bronchus and a single right main stem
bronchus for the left and right lungs,Shashi
04/13/09
Asthma-Pathology -14
04/13/09 Shashi
Asthma-Pathology -15
Asthma
04/13/09 Shashi
Asthma-Pathology -16
Pathophysiolo INDUCERS
gy: Allergens,Chemical sensitizers,
Airway Air pollutants, Virus infections
Hyperresponsiveness
Genetic*
INFLAMMATION
Airflow Limitation
TRIGGERS
SYMPTOMS
Allergens, Exercise,
Cough Wheeze
Cold Air, SO2 Particulates
Dyspnea
04/13/09 Shashi
Asthma-Pathology -17 Contributing Factors
Causal Factors >Respriratory infections
Predisposing Factor >Exposure to indoor
Atopy >Air pollution
And outdoor allergens >Active/passive smoking
Female gender
>Occupational >Others diet, small size
sensitizers at birth
Inflammation
Hyperresponsiveness
of airways Airflow limitation
Symptoms
Risk Factors for Wheezing
Exacerbations Cough
Allergens
Dyspnea
Respiratory infections
Chest tightness
Exercise and hyperventilation
Weather changes
Exposure to sulfur dioxide
Exposure to food, additives,
04/13/09 medications Shashi
Asthma-Pathology -18
Pathogenesis - Atopic
Asthma:
04/13/09 Shashi
Asthma-Pathology -19
04/13/09 Shashi
Asthma-Pathology -20
Eosinophils in Asthma
Pathogenesis:
04/13/09 Shashi
Asthma-Pathology -21
04/13/09 Shashi
Asthma-Pathology -22
04/13/09 Shashi
Asthma-Pathology -23
04/13/09 Shashi
Asthma-Pathology -24
Asthma Microscopic
Pathology
Obstructed
Inflammed
Bronchi
04/13/09 Shashi
Asthma-Pathology -25
inflammation
Eosinophils
Gland
hyperplasia
Mucous plug in
lumen
Hypertrophy of
muscle layer
04/13/09 Shashi
Asthma-Pathology -26
04/13/09 Shashi
Asthma-Pathology -27
04/13/09 Shashi
Asthma-Pathology -28
04/13/09 Shashi
Asthma-Pathology -29
Eosinophils in Asthma:
04/13/09 Shashi
Asthma-Pathology -30
Medical Management
medications
Quick relief (rescue)
medications
04/13/09 Shashi
Asthma-Pathology -31
Long-term control
medications
-- used on a regular basis to prevent attacks, not
for treatment during an attack.
inhaled steroids (e.g., Azmacort, Vanceril,
AeroBid, Flovent) prevent inflammation
leukotriene inhibitors (e.g., Singulair, Accolate)
long-acting bronchodilators (e.g., famoterol,
Serevent) help open airways
cromolyn sodium (Intal) or nedocromil sodium
aminophylline or theophylline (not used as
frequently as in the past)
combination of anti-inflammatory and
bronchodilator, using either separate inhalers
or a single inhaler (Advair Diskus)
04/13/09 Shashi
Asthma-Pathology -32
(e.g., prednisone,
methylprednisolone) stabilize
severe episodes
04/13/09 Shashi
Asthma-Pathology -33
LTD4
Bronchospasm – Cys-LT1 receptor
CysLT1
04/13/09 Shashi
Asthma-Pathology -34
Cell Damage
Cell Membrane
Phospholipids
Steroids
Arachidonic
Acid Cyclooxygenas
5-Lipoxygenase
NSAID e
Prostaglandins
Leukotrienes
Prostacyclins
LTC4, D4, E4
5-LO inhibitors
Antileukotrienes
04/13/09 Shashi
Asthma-Pathology -35
The Reality
Asthma is not yet curable *
Underdiagnosis &
Undermanagement
Therapy is still evolving
Hope
Better understanding of
Pathology
New line of Promissing Drugs.
04/13/09
Proper management normalShashi
Thank You…
04/13/09
Asthma-Pathology -37
References
Joyce Black, Medical and Surgical Nursing, 8th
edition, 2005
Saunder’s, Comprehensive Review for NCLEX,
2006
Brunner And Suddarth, Medical and Surgical
Nursing, 6th Edition, 2005
Berto, J.M.; Pelaez, A.; Fernandez E; A new indoor
source of Allergic sensitization & respiratory
disease. Allergy, 2002, 57, 155-159
Murray JF, Nadel JA, eds. Textbook of Respiratory
Medicine. Vol. 1, 3rd ed. Philadelphia, Pa.: W.B.
Saunders; 2000.
Shier D, Butler J, Lewis R. Hole's Human Anatomy
and Physiology. 7th ed. Dubuque, Iowa: William C
Brown Publishers; 1996.
www.allrefer.com
04/13/09 Shashi